These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7201207)

  • 1. [Platinum derivatives in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1982; 28(5):38-43. PubMed ID: 7201207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1989; 35(3):325-30. PubMed ID: 2705315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
    Ribaud P; Gouveia J; Bonnay M; Mathe G
    Cancer Treat Rep; 1981; 65 Suppl 3():97-105. PubMed ID: 7049371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complex compounds of platinum in the chemotherapy of malignant tumors].
    Presnov MA; Konovalova AL; Korol'chuk VP
    Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504
    [No Abstract]   [Full Text] [Related]  

  • 5. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
    Mechl Z; Krejcí P
    Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
    Polyzos A; Kosmas C; Tsavaris N; Toufexi H; Lagadas A; Gogas H; Giannakopoulos K; Kouraklis G; Griniatsos J; Felekouras E; Tsigris C; Nikiteas N; Papadopoulos O; Giannopoulos A
    Anticancer Res; 2007; 27(3B):1645-51. PubMed ID: 17595790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of chemotherapy with platinum compounds.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coordinated platinum compounds in experimental and clinical oncology].
    Lobanova EA; Kozlova MD; Singin AS; Serebriakov NG
    Med Radiol (Mosk); 1984 Jun; 29(6):59-63. PubMed ID: 6376996
    [No Abstract]   [Full Text] [Related]  

  • 10. Platinum complexes in cancer chemotherapy.
    Antibiot Chemother (1971); 1978; 23():99-112. PubMed ID: 348089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticancer drugs used in medicine and being in clinical research].
    Malinowska K; Modranka R; Kedziora J
    Pol Merkur Lekarski; 2007 Sep; 23(135):165-9. PubMed ID: 18080687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin and platinum drugs at the molecular level. (Review).
    Boulikas T; Vougiouka M
    Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum-based chemotherapy in metastatic breast cancer: current status.
    Decatris MP; Sundar S; O'Byrne KJ
    Cancer Treat Rev; 2004 Feb; 30(1):53-81. PubMed ID: 14766126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M; Brandolini C; Ferri GG; Hatzopoulos S; Prete A; Pession A
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.